Amelia Langston MD
Academic Appointment
- Professor of Hematology and Medical Oncology, Clinical Track, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
Education
Degrees
- BA from Williams College
- MD from Washington University School of Medicine
Research
Focus
- My research focuses on novel strategies for autologous and allogeneic stem cell transplantation. I also study prevention methods and treatment of opportunistic infections in immunocompromised patients, along with the use of biologically targeted agents for antileukemic therapy.
Publications
-
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
Transplant Cell Ther Volume: 31 Page(s): 109.e1 - 109.e13
02/01/2025 Authors: Takahashi T; Watkins B; Bratrude B; Neuberg D; Hebert K; Betz K; Yu A; Choi SW; Davis J; Duncan C -
(Donor) age is more than just a number.
Bone Marrow Transplant Volume: 60 Page(s): 1 - 2
01/01/2025 Authors: Vale C; Langston AA -
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
Blood Volume: 144 Page(s): 1834 - 1845
10/24/2024 Authors: Kean LS; Burns LJ; Kou TD; Kapikian R; Lozenski K; Langston A; Horan JT; Watkins B; Qayed M; Bratrude B -
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G-CSF and Plerixafor: A single center project.
J Clin Apher Volume: 39 Page(s): e22127
06/01/2024 Authors: Javanbakht A; Stringer S; Anderson H; Hamilton E; Philip A; Waller EK; Langston AA; Joseph N; Roback JD; Schneider T -
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
Bone Marrow Transplant Volume: 59 Page(s): 680 - 687
05/01/2024 Authors: Gorfinkel L; Raghunandan S; Watkins B; Hebert K; Neuberg DS; Bratrude B; Betz K; Yu A; Choi SW; Davis J -
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
Circulation Volume: 149 Page(s): e1113 - e1127
04/16/2024 Authors: Hayek SS; Zaha VG; Bogle C; Deswal A; Langston A; Rotz S; Vasbinder A; Yang E; Okwuosa T; American Heart Association Cardio-Oncology Committee of the Council on Clinical Cardiology and Council on Genomic and Precision Medicine; and the Council on Cardiovascular and Stroke Nursing -
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS -
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
Bone Marrow Transplant Volume: 58 Page(s): 1264 - 1266
11/01/2023 Authors: Raghunandan S; Qayed M; Watkins BK; Graiser M; Gorfinkel L; Westbrook A; Gillespie S; Bratrude B; Petrovic A; Suessmuth Y -
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.
Blood Adv Volume: 7 Page(s): 5189 - 5198
09/12/2023 Authors: Al Malki MM; London K; Baez J; Akahoshi Y; Hogan WJ; Etra A; Choe H; Hexner E; Langston A; Abhyankar S -
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood Volume: 142 Page(s): 700 - 710
08/24/2023 Authors: Takahashi T; Al-Kofahi M; Jaber M; Bratrude B; Betz K; Suessmuth Y; Yu A; Neuberg DS; Choi SW; Davis J -
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
Blood Adv Volume: 7 Page(s): 4395 - 4399
08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS -
Passenger pathogens on physicians.
Am J Infect Control Volume: 51 Page(s): 807 - 811
07/01/2023 Authors: Funk CR; Ravindranathan S; Matelski A; Zhang H; Taylor C; Chandrasekaran S; Arellano M; Langston AA; Joseph N; Waller EK -
Effective treatment of low-risk acute GVHD withitacitinib monotherapy.
Blood Volume: 141 Page(s): 481 - 489
02/02/2023 Authors: Etra A; Capellini A; Alousi A; Al Malki MM; Choe H; DeFilipp Z; Hogan WJ; Kitko CL; Ayuk F; Baez J -
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
Blood Adv Volume: 6 Page(s): 746 - 749
02/08/2022 Authors: Qayed M; Watkins B; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C; Giller R; Grimley M -
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
Front Immunol Volume: 13 Page(s): 959658
01/01/2022 Authors: Stenger E; Giver CR; Langston A; Kota D; Das PK; Chinnadurai R; Galipeau J; Waller EK; Qayed M -
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood Volume: 138 Page(s): 2278 - 2289
12/02/2021 Authors: Cutler C; Lee SJ; Arai S; Rotta M; Zoghi B; Lazaryan A; Ramakrishnan A; DeFilipp Z; Salhotra A; Chai-Ho W -
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies.
Transplant Cell Ther Volume: 27 Page(s): 837.e1 - 837.e10
10/01/2021 Authors: Saber W; Steinert P; Zhang M-J; Chen M; Pope A; Keating A; Wingard JR; Ballen K; Stiff P; Perales M-A -
Cytomegalovirus immunoglobulin G: passive transfer or prior infection?
Br J Haematol Volume: 195 Page(s): 11 - 12
10/01/2021 Authors: Byrne M; Langston AA; Booth GS -
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Blood Adv Volume: 5 Page(s): 3528 - 3539
09/28/2021 Authors: Herrera AF; Ahn KW; Litovich C; Chen Y; Assal A; Bashir Q; Bayer R-L; Coleman M; DeFilipp Z; Farhadfar N -
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
J Clin Oncol Volume: 39 Page(s): 1865 - 1877
06/10/2021 Authors: Watkins B; Qayed M; McCracken C; Bratrude B; Betz K; Suessmuth Y; Yu A; Sinclair S; Furlan S; Bosinger S -
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica Volume: 106 Page(s): 1599 - 1607
06/01/2021 Authors: Cooper JP; Storer BE; Granot N; Gyurkocza B; Sorror ML; Chauncey TR; Shizuru J; Franke G-N; Maris MB; Boyer M -
Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
Br J Haematol Volume: 193 Page(s): 701 - 702
05/01/2021 Authors: Booth GS; Savani BN; Langston AA -
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
JCO Oncol Pract Volume: 17 Page(s): e497 - e505
04/01/2021 Authors: Jillella AP; Arellano ML; Gaddh M; Langston AA; Heffner LT; Winton EF; McLemore ML; Zhang C; Caprara CR; Simon KS -
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
EClinicalMedicine Volume: 33
03/19/2021 Authors: Ljungman P; Bermudez A; Logan AC; Kharfan-Dabaja MA; Chevallier P; Martino R; Wulf G; Selleslag D; Kakihana K; Langston A -
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.
Volume: 33 Page(s): 100787
03/01/2021 Authors: Ljungman P; Bermudez A; Logan AC; Kharfan-Dabaja MA; Chevallier P; Martino R; Wulf G; Selleslag D; Kakihana K; Langston A -
Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Open Forum Infect Dis Volume: 8 Page(s): ofab092
03/01/2021 Authors: Sherman AC; Lu X; Schneider E; Langston A; Ellis CL; Pastan S; Bhatnagar J; Reagan-Steiner S; Annambhotla P; Lindstrom S -
Why does the place where the allogeneic transplant patient calls home matter?
Cancer Volume: 127 Page(s): 510 - 511
02/15/2021 Authors: Langston AA -
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.
Sci Transl Med Volume: 13
01/13/2021 Authors: Tkachev V; Kaminski J; Potter EL; Furlan SN; Yu A; Hunt DJ; McGuckin C; Zheng H; Colonna L; Gerdemann U -
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer.
Oncologist Volume: 25 Page(s): e1586 - e1588
10/01/2020 Authors: Langston AA; Quest TE; Abernethy ER; Campbell GP; Owonikoko TK; Pentz RD -
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
Cancer Volume: 126 Page(s): 1235 - 1242
03/15/2020 Authors: Cohen JB; Wei L; Maddocks KJ; Christian B; Heffner LT; Langston AA; Lechowicz MJ; Porcu P; Flowers CR; Devine SM -
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience.
Bone Marrow Transplant Volume: 55 Page(s): 172 - 181
01/01/2020 Authors: Shadman M; Maloney DG; Storer B; Sandmaier BM; Chauncey TR; Smedegaard Andersen N; Niederwieser D; Shizuru J; Bruno B; Pulsipher MA -
ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.
Hematol Rep Volume: 11 Page(s): 8395
11/29/2019 Authors: Jillella AP; Arellano ML; Heffner LT; Gaddh M; Langston AA; Khoury HJ; Mangaonkar A; Kota VK -
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
Clin Cancer Res Volume: 25 Page(s): 5143 - 5155
08/15/2019 Authors: Kim HT; Ahn KW; Hu Z-H; Davids MS; Volpe VO; Antin JH; Sorror ML; Shadman M; Press O; Pidala J -
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Lancet Haematol Volume: 6 Page(s): e409 - e418
08/01/2019 Authors: Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA -
Follow-up to comment on "Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis".
J Thromb Haemost Volume: 17 Page(s): 1007 - 1009
06/01/2019 Authors: Elsebaie MAT; Van Es N; Langston A; Bller HR; Gaddh M -
Acute Myeloid Leukemia in Young Adults: Does Everyone Need a Transplant?
J Oncol Pract Volume: 15 Page(s): 315 - 320
06/01/2019 Authors: Roberts MMSc D; Langston AA; Heffner LT -
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
Clin Infect Dis Volume: 68 Page(s): 1255 - 1264
04/08/2019 Authors: Papanicolaou GA; Silveira FP; Langston AA; Pereira MR; Avery RK; Uknis M; Wijatyk A; Wu J; Boeckh M; Marty FM -
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Volume: 17 Page(s): 645 - 656
04/01/2019 Authors: Elsebaie MAT; van Es N; Langston A; Bller HR; Gaddh M -
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Volume: 25 Page(s): 369 - 381
02/01/2019 Authors: Marty FM; Winston DJ; Chemaly RF; Mullane KM; Shore TB; Papanicolaou GA; Chittick G; Brundage TM; Wilson C; Morrison ME -
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Cancer Volume: 125 Page(s): 185 - 193
01/15/2019 Authors: Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR -
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
Int J Mol Sci Volume: 19
12/19/2018 Authors: Funk CR; Petersen CT; Jagirdar N; Ravindranathan S; Jaye DL; Flowers CR; Langston A; Waller EK -
Safety and Efficacy of Evomela in Myeloma Autotransplants
Volume: 132
11/29/2018 Authors: Amelsberg K; Joseph N; Langston A; Kaufman JL; Hofmeister CC; Waller EK; Graiser M; Larocco R; Heffner L; Dhodapkar MV -
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.
J Clin Oncol Volume: 36 Page(s): 3043 - 3054
10/20/2018 Authors: Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston KV -
TREATMENT OF VENOUS THROMBOEMBOLISM DURING INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE LEUKEMIA: A SINGLE CENTER EXPERIENCE
Volume: 93 Page(s): E51 - E51
09/01/2018 Authors: Patel B; Cheng E; McLemore M; Arellano M; Heffner LT; Winton EF; Bodo I; Langston A; Kota V; Gaddh M -
Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease.
Bone Marrow Transplant Volume: 53 Page(s): 826 - 831
07/01/2018 Authors: Khoury HJ; Langston AA; Kota VK; Wilkinson JA; Pusic I; Jillella A; Bauer S; Kim AS; Roberts D; Al-Kadhimi Z -
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
J Clin Oncol Volume: 36 Page(s): 1443 - 1453
05/10/2018 Authors: Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston K -
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant Volume: 24 Page(s): 973 - 982
05/01/2018 Authors: Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD -
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.
Leuk Lymphoma Volume: 59 Page(s): 837 - 843
04/01/2018 Authors: Dhere V; Edelman S; Waller EK; Langston A; Graiser M; Connolly EC; Switchenko JM; Esiashvili N; Khan MK -
Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT)
Volume: 24 Page(s): S135 - S136
03/01/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff J; Gupta V; Lechowicz M; Al-Kadhimi Z; Nooka A; Kaufman J; Lonial S -
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Cancer Volume: 124 Page(s): 816 - 825
02/15/2018 Authors: Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN -
Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths
Volume: 130
12/07/2017 Authors: Kota V; Arellano ML; Kharkhanis P; Bolds S; Caprara CR; Simon KS; Debragga S; Gaddh M; Bernal-Mizrachi L; Heffner L -
Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant - Obesity Associated with Inferior Outcomes
Volume: 130
12/07/2017 Authors: Ip A; Switchenko JM; Graiser M; Koff JL; Gupta VA; Nooka AK; Al-Kadhimi Z; Lechowicz MJ; Kaufman JL; Lonial S -
T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival
Volume: 130
12/07/2017 Authors: Watkins B; Qayed M; Bratrude B; Betz K; Brown M; Rhodes J; Sinclair S; Suessmuth Y; Yu A; Hebert K -
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.
Hematol Rep Volume: 9 Page(s): 7083
09/26/2017 Authors: Jillella AP; Arellano ML; Heffner LT; Gaddh M; Langston AA; Khoury HJ; Mangoankar A; Kota VK -
Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.
Volume: 52 Page(s): 1304 - 1310
09/01/2017 Authors: Al-Kadhimi Z; Gul Z; Abidi M; Lum LG; Deol A; Chen W; Jang H; Ozust C; Langston A; Waller E -
Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention
BONE MARROW TRANSPLANTATION Volume: 52 Page(s): 1304 - 1310
09/01/2017 Authors: Al-Kadhimi Z; Gul Z; Abidi M; Lum LG; Deol A; Chen W; Jang H; Ozust C; Langston A; Waller E -
Opportunity for Collaboration Between Radiation Injury Treatment Network Centers and Medical Toxicology Specialists.
South Med J Volume: 110 Page(s): 497 - 501
08/01/2017 Authors: Davlantes E; Shartar S; Venero J; Steck A; Langston A; Kazzi ZN -
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
Cancer Volume: 123 Page(s): 2482 - 2488
07/01/2017 Authors: Kong JH; Winton EF; Heffner LT; Chen Z; Langston AA; Hill B; Arellano M; El-Rassi F; Kim A; Jillella A -
Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 17S Page(s): S96 - S99
07/01/2017 Authors: Staton AD; Langston AA -
Dose dependent association of early red blood cell transfusion with increased risk of graft versus host disease and worse survival after allogeneic hematopoietic stem cell transplantation
Volume: 52 Page(s): S207 - S208
07/01/2017 Authors: Waller EK; Hosoba S; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Easley KA; Josephson CD; Khoury HJ; Koff JL -
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.
Infect Control Hosp Epidemiol Volume: 38 Page(s): 651 - 657
06/01/2017 Authors: Shah NN; McClellan W; Flowers CR; Lonial S; Khoury H; Waller EK; Langston A; Nooka AK -
Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Solid Organ Transplant Recipients: A Phase 2 Study
Volume: 17 Page(s): 405 - 405
04/01/2017 Authors: Pereira M; Silveira F; Papanicolaou G; Langston A; Avery R; Wijatyk A; Wu J; Boeckh M; Marty F; Villano S -
Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
Transpl Infect Dis Volume: 19
02/01/2017 Authors: Aldrete SDM; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R -
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
Bone Marrow Transplant Volume: 52 Page(s): 132 - 134
01/01/2017 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Al-Kadhimi Z; Cohen JB; Flowers CR -
A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States
Volume: 128
12/02/2016 Authors: Kota V; Karkhanis P; Sharma R; Bolds S; Sitchenko K; Shrestha A; Jonnalagadda V; Gaddh M; Bernal-Mizrachi L; Heffner LT -
A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States
Volume: 128
12/02/2016 Authors: Jillella A; Karkhanis P; Sharma R; Bolds S; Shrestha A; Sitchenko K; Jonnalagadda V; Gaddh M; Bernal-Mizrachi L; Heffner LT -
Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial
Volume: 128
12/02/2016 Authors: Sandmaier BM; Maloney DG; Storer BE; Olesen G; Maris MB; Gutman JA; Petersen SL; Langston A; Chauncey T; Bethge W -
Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E493 - E494
10/01/2016 Authors: Edelman S; Waller EK; Graiser M; Langston AA; Dhere V; Mikell JL; Switchenko JM; Esiashvili N; Khan MK -
Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia
Volume: 96 Page(s): E493 - E494
10/01/2016 Authors: Edelman S; Waller EK; Graiser M; Langston AA; Dhere V; Mikell JL; Switchenko JM; Esiashvili N; Khan MK -
Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia
Volume: 96 Page(s): E493 - E494
10/01/2016 Authors: Edelman S; Waller EK; Graiser M; Langston AA; Dhere V; Mikell JL; Switchenko JM; Esiashvili N; Khan MK -
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
Clin Lymphoma Myeloma Leuk Volume: 16 Page(s): 466 - 471.e1
08/01/2016 Authors: DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R -
Erratum to Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease [J Antimicrob Chemother 2016; 71: 718-726]
Journal of Antimicrobial Chemotherapy Volume: 71 Page(s): 1747
06/13/2016 Authors: Cornely OA; Duarte RF; Haider S; Chandrasekar P; Helfgott D; Jimnez JL; Candoni A; Raad I; Laverdiere M; Langston A -
DECREASING EARLY DEATHS IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN AN ACADEMIC CENTER IN THE US BY USING A SIMPLIFIED TREATMENT ALGORITHM AND DEDICATED APL EXPERTS
Volume: 101 Page(s): 675 - 676
06/01/2016 Authors: Jillella A; Mody M; Harpaul G; Arellano M; Khoury H; Al-Kadhimi Z; McLemore M; Winton E; Gaddh M; Heffner L -
Costs associated with induction chemotherapy in adult acute myeloid leukemia (AML) managed in a tertiary care specialized unit.
Volume: 34
05/20/2016 Authors: Gleason S; Howard DH; Liu Y; Goldstein DA; Arellano ML; Jillella AP; Gaddh M; Kota V; Winton EF; Heffner LT -
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
J Antimicrob Chemother Volume: 71 Page(s): 718 - 726
03/01/2016 Authors: Cornely OA; Duarte RF; Haider S; Chandrasekar P; Helfgott D; Jimnez JL; Candoni A; Raad I; Laverdiere M; Langston A -
Tailored Post-Transplant Maintenance with Tyrosine Kinase Inhibitors for High-Risk Philadelphia Chromosome-Positive Leukemia
Volume: 22 Page(s): S313 - S313
03/01/2016 Authors: DeFilipp Z; Langston AA; Kota VK; Al-Kadhimi Z; Jillella AP; Waller EK; Khoury HJ -
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
Biol Blood Marrow Transplant Volume: 22 Page(s): 359 - 370
02/01/2016 Authors: Young J-AH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER -
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
Bone Marrow Transplant Volume: 51 Page(s): 277 - 282
02/01/2016 Authors: Riches ML; Trifilio S; Chen M; Ahn KW; Langston A; Lazarus HM; Marks DI; Martino R; Maziarz RT; Papanicolou GA -
Erratum: Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: A CIBMTR infection and immune reconstitution analysis (Bone Marrow Transplantation (2016) 51 (277-282) DOI:10.1038/bmt.2015.263)
Bone Marrow Transplantation Volume: 51 Page(s): 322
02/01/2016 Authors: Riches ML; Trifilio S; Chen M; Ahn KW; Langston A; Lazarus HM; Marks DI; Martino R; Maziarz RT; Papanicolou GA -
Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital.
J Stem Cell Res Ther Volume: 6
01/01/2016 Authors: Yun HD; Dossul T; Bernal-Mizrachi L; Switchenko J; Ndibe C; Ibraheem A; Dixon MD; Langston AA; Nooka AK; Flowers CR -
Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience
Volume: 126
12/03/2015 Authors: Zeichner SB; Gleason S; Antun AG; Langston A; Heffner LT; Kota VK; Gaddh M; Arellano M -
Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA
Volume: 126
12/03/2015 Authors: Jillella A; Arellano M; Bashey A; Vidito SI; Stuart RK; Leung C; Sitchenko K; Gaddh M; Heffner LT; Kolhe RB -
Suvmax in 18-Fluorodeoxyglucose PET/CT Potentially Predict the Estimation of a Positive Biopsy in Cases of Lymphoma
Volume: 126
12/03/2015 Authors: Chandra P; Akinbobuyi O; Liao A; Arora J; Chen Z; Lechowicz MJ; Langston AA; Kowalsky J; Cohen JB; Flowers CR -
Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant
Volume: 126
12/03/2015 Authors: Lee MJ; Switchenko J; Thomas JS; Koff JL; Nastoupil L; Lechowicz MJ; Langston AA; Flowers C; Cohen JB -
Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)
Volume: 126
12/03/2015 Authors: Khoury HJ; Kota V; Arellano M; Bauer SL; Jillella AP; Langston A; Al-Kadhimi Z; DeFilipp Z; Kim AS; Winton EF -
A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
Volume: 126
12/03/2015 Authors: Cohen JB; Wei L; Maddocks KJ; Heffner LT; Langston A; Flowers C; Devine SM; Blum KA -
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
Volume: 171 Page(s): 539 - 546
11/01/2015 Authors: Cohen JB; Switchenko JM; Koff JL; Sinha R; Kaufman JL; Khoury HJ; Bumpers N; Colbert A; Hutchison-Rzepka A; Nastoupil LJ -
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma
British Journal of Haematology Volume: 171 Page(s): 539 - 546
11/01/2015 Authors: Cohen JB; Switchenko JM; Koff JL; Sinha R; Kaufman JL; Khoury HJ; Bumpers N; Colbert A; Hutchison-Rzepka A; Nastoupil LJ -
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Cancer Volume: 121 Page(s): 3709 - 3716
10/15/2015 Authors: Vaughn JE; Sorror ML; Storer BE; Chauncey TR; Pulsipher MA; Maziarz RT; Maris MB; Hari P; Laport GG; Franke GN -
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial.
Transfusion Volume: 55 Page(s): 2351 - 2357
10/01/2015 Authors: Jagirdar N; Harvey RD; Nooka A; Flowers C; Kaufman J; Lonial S; Lechowicz MJ; Langston A; Lipscomb C; Gaylor C -
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: Results of a Phase II clinical trial
Transfusion Volume: 55 Page(s): 2351 - 2357
10/01/2015 Authors: Jagirdar N; Harvey RD; Nooka A; Flowers C; Kaufman J; Lonial S; Lechowicz MJ; Langston A; Lipscomb C; Gaylor C -
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 15 Page(s): 514 - 518
09/01/2015 Authors: Cohen JB; Bucur S; Winton EF; Sinha R; Heffner LT; King N; Lonial S; Langston AA; Waller EK; Hutchison-Rzepka A -
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR repertoire.
Blood Volume: 125 Page(s): 3835 - 3850
06/18/2015 Authors: Suessmuth Y; Mukherjee R; Watkins B; Koura DT; Finstermeier K; Desmarais C; Stempora L; Horan JT; Langston A; Qayed M -
Bloodless transplants for multiple myeloma are feasible and yield similar results as matched controls.
Volume: 33
05/20/2015 Authors: Obidike CO; Nooka AK; Kaufman JL; Heffner LT; Langston AA; Lonial S -
A phase I study of gemcitabine and bendamustine in relapsed/refractory Hodgkin's lymphoma
Volume: 33
05/20/2015 Authors: Cohen JB; Wei L; Maddocks KJ; Heffner LT; Langston AA; Flowers C; Devine SM; Blum KA -
Improving Test Utilization for Chimerism Analysis After Hematopoietic Stem Cell Transplantation
Volume: 143 Page(s): A48 - A48
05/01/2015 Authors: Stelton C; Geller R; Waller E; Langston A; Gebel H; Jaye D -
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Leuk Lymphoma Volume: 56 Page(s): 383 - 389
02/01/2015 Authors: Nastoupil LJ; Shenoy PJ; Ambinder A; Koff JL; Nooka AK; Waller EK; Langston A; Seward M; Kaufman JL; Bernal-Mizrachi L -
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Volume: 21 Page(s): S69 - S70
02/01/2015 Authors: Suessmuth Y; Koura D; Finstermeier K; Desmarais C; Horan J; Langston A; Qayed M; Khoury HJ; Watkins BK; Robins H -
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Volume: 21 Page(s): S88 - S89
02/01/2015 Authors: Vaughn J; Sorror ML; Chauncey T; Pulsipher MA; Maziarz RT; Maris MB; Hari PN; Laport GG; Franke G-N; Agura E -
Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation
Volume: 124
12/06/2014 Authors: Yun HD; Dossul T; Bernal-Mizrachi L; Switchenko J; Ndibe C; Ibraheem A; Langston A; Pentz R; Waller EK -
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.
Clin Lymphoma Myeloma Leuk Volume: 14 Page(s): e213 - e215
12/01/2014 Authors: Shams SR; Goldstein DA; Kaufman JL; MacKelfresh J; Flowers CR; Langston AA -
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
Haematologica Volume: 99 Page(s): 1624 - 1631
10/01/2014 Authors: Kornblit B; Maloney DG; Storer BE; Maris MB; Vindelv L; Hari P; Langston AA; Pulsipher MA; Bethge WA; Chauncey TR -
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
Antimicrob Agents Chemother Volume: 58 Page(s): 5758 - 5765
10/01/2014 Authors: Duarte RF; Lpez-Jimnez J; Cornely OA; Laverdiere M; Helfgott D; Haider S; Chandrasekar P; Langston A; Perfect J; Ma L -
Incidence and geographic distribution of adult acute leukemia in the state of Georgia.
South Med J Volume: 107 Page(s): 497 - 500
08/01/2014 Authors: El Rassi F; Ward KC; Flowers CR; Heffner LT; Waller EK; Winton EF; Vaughn J; Hill BG; Langston A; Nooka A -
CMV Reactivation Drives Accelerated Immune Aging After Bone Marrow Transplant
Volume: 98 Page(s): 178 - 179
07/15/2014 Authors: Suessmuth Y; Cheeseman J; Stempora L; Garrett A; Finstermeier K; Desmarais C; Langston A; Kirk A; Mehta A; Kean L -
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma.
Leuk Lymphoma Volume: 55 Page(s): 1498 - 1500
07/01/2014 Authors: Mitri Z; Siddiqui MT; El Rassi F; Holden JT; Heffner LT; Langston A; Waller EK; Winton E; McLemore M; Bernal-Mizrachi L -
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant Volume: 20 Page(s): 852 - 857
06/01/2014 Authors: Nooka AK; Johnson HR; Kaufman JL; Flowers CR; Langston A; Steuer C; Graiser M; Ali Z; Shah NN; Rangaraju S -
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.
Int J Radiat Oncol Biol Phys Volume: 89 Page(s): 360 - 369
06/01/2014 Authors: Mikell JL; Waller EK; Switchenko JM; Rangaraju S; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khoury HJ -
CMV Reactivation Drives Accelerated Immune Aging After Bone Marrow Transplant
Volume: 14 Page(s): 178 - 179
06/01/2014 Authors: Suessmuth Y; Cheeseman J; Stempora L; Garrett A; Finstermeier K; Desmarais C; Langston A; Kirk A; Mehta A; Kean L -
Survival trends of myeloma patients in the new millennium.
Volume: 32
05/20/2014 Authors: Gleason C; Nooka AK; Langston AA; Shah NN; Kaufman JL; Lonial S -
Causes of mortality in patients with plasma cell disorders.
Volume: 32
05/20/2014 Authors: Nooks AK; Kaufman JL; Langston AA; Lonial S -
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
Clin Lymphoma Myeloma Leuk Volume: 14 Page(s): e59 - e63
04/01/2014 Authors: Nooka AK; Harvey RD; Langston A; Collins H; Lonial S; Kaufman JL -
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients.
Leukemia Volume: 28 Page(s): 690 - 693
03/01/2014 Authors: Nooka AK; Kaufman JL; Muppidi S; Langston A; Heffner LT; Gleason C; Casbourne D; Saxe D; Boise LH; Lonial S -
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
Bone Marrow Transplant Volume: 49 Page(s): 185 - 189
02/01/2014 Authors: Langston AA; Prichard JM; Muppidi S; Nooka A; Lechowicz MJ; Lonial S; Sinha R; Graiser M; Kaufman JL; Khoury HJ -
Simplified Technique for Administration of High Dose Melphalan
Volume: 20 Page(s): S291 - S292
02/01/2014 Authors: Hutcherson D; Valla K; Shah KS; Surati M; French K; Nooka A; Kaufman J; Lonial S; Cohen JB; Langston A -
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients
Leukemia Volume: 28 Page(s): 690 - 693
01/01/2014 Authors: Nooka AK; Kaufman JL; Muppidi S; Langston A; Heffner LT; Gleason C; Casbourne D; Saxe D; Boise LH; Lonial S -
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema
Clinical Lymphoma, Myeloma and Leukemia Volume: 14 Page(s): e213 - e215
01/01/2014 Authors: Shams SR; Goldstein DA; Kaufman JL; MacKelfresh J; Flowers CR; Langston AA -
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.
Cancer Volume: 119 Page(s): 4119 - 4128
12/01/2013 Authors: Nooka AK; Kaufman JL; Behera M; Langston A; Waller EK; Flowers CR; Gleason C; Boise LH; Lonial S -
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 13 Page(s): 657 - 663
12/01/2013 Authors: Sinha R; Shenoy PJ; King N; Lechowicz MJ; Bumpers K; Hutcherson D; Arellano M; Langston A; Kaufman J; Heffner LT -
Using Serum Free Light Chain (SFLC) Ratio and Serum Protein Electrophoresis (SPEP) As a Substitute For 24-Hour Urine Studies In Myeloma Patients
Volume: 122
11/15/2013 Authors: Shah NN; Nooka AK; Harvey D; Kaufman JL; Langston A; Nickleach D; Gleason C; Heffner LT; Boise LH; Lonial S -
Evaluating Risk Factors and Outcomes For Clostridium Difficile Infection (CDI) In Stem Cell Transplant (SCT) Recipients
Volume: 122
11/15/2013 Authors: Shah NN; Nooka AK; Kaufman JL; Casbourne D; Hutcherson D; Maynard R; Waller EK; Lonial S; Langston A -
Indications For Hospital Admissions and Outcomes Of Hospitalization Among Multiple Myeloma Patients In The U.S: Data From National Inpatient Sample
Volume: 122
11/15/2013 Authors: Nooka AK; Kaufman JL; Shah NN; Langston A; Collins H; Boise LH; Lonial S -
Hospitalization Outcome Metrics Based On Payer Status In Myeloma Patients That Receive Autologous Stem Cell Transplant (ASCT)
Volume: 122
11/15/2013 Authors: Gowda S; Langston A; Kaufman JL; Shah NN; Lechowicz MJ; Boise LH; Lonial S; Nooka AK -
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1638 - 1649
11/01/2013 Authors: Koura DT; Horan JT; Langston AA; Qayed M; Mehta A; Khoury HJ; Harvey RD; Suessmuth Y; Couture C; Carr J -
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Cancer Volume: 119 Page(s): 3784 - 3787
11/01/2013 Authors: Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT -
Similar Survival for Patients Undergoing Reduced-Intensity TBI Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia
Volume: 87 Page(s): S558 - S558
10/01/2013 Authors: Mikell JL; Waller EK; Rangaraju S; Switchenko JM; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khan MK -
Advances in hematopoietic stem cell transplantation in chronic myeloid leukemia.
Discov Med Volume: 16 Page(s): 179 - 186
10/01/2013 Authors: Veldman R; El Rassi F; Holloway S; Langston A; Khoury HJ -
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1393 - 1395
09/01/2013 Authors: Harvey RD; Kaufman JL; Johnson HR; Nooka A; Vaughn L; Flowers CR; Khoury HJ; Lechowicz MJ; Langston AA; Lonial S -
Inherited predisposition to multiple myeloma.
Ther Adv Hematol Volume: 4 Page(s): 291 - 297
08/01/2013 Authors: Koura DT; Langston AA -
ELIMINATING THE NEED FOR 24-HOUR URINE STUDIES IN PHASE I MYELOMA PATIENTS
Volume: 98 Page(s): 598 - 598
06/12/2013 Authors: Shah N; Kaufman J; Langston A; Waller E; Boise L; Harvey R; Lonial S; Nooka A -
Outcomes of hematopoietic stem cell transplant recipients admitted to the medical intensive care unit.
Volume: 31
05/20/2013 Authors: Duc QT; Langston AA; Waller EK; Simon M; Gleason C; Casbourne D; Fisher M; Kaufman JL; Flowers C; Lonial S -
Survival outcomes of plasma cell leukemia (PCL) in the United States: A SEER analysis
Volume: 31
05/20/2013 Authors: Ravipati HP; Kaufman JL; Langston AA; Boise L; Flowers C; Lonial S; Nooka AK -
Early versus delayed autologous stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for newly diagnosed multiple myeloma (MM)
Volume: 31
05/20/2013 Authors: Nooka AK; Langston AA; Waller EK; Heffner LT; Gleason C; Muppidi S; Watson M; Casbourne D; Boise L; Kaufman JL -
Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation.
J Pediatr Hematol Oncol Volume: 35 Page(s): e149 - e152
05/01/2013 Authors: Qayed M; Langston A; Chiang K-Y; August K; Hilinski JA; Cole CR; Rogatko A; Bostick RM; Horan JT -
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
J Clin Oncol Volume: 31 Page(s): 1530 - 1538
04/20/2013 Authors: Storb R; Gyurkocza B; Storer BE; Sorror ML; Blume K; Niederwieser D; Chauncey TR; Pulsipher MA; Petersen FB; Sahebi F -
Single centre pharmacoeconomic analysis of palifermin in autologous stem cell transplantation
Volume: 48 Page(s): S453 - S453
04/01/2013 Authors: Johnson HR; Nooka A; Kaufman J; Flowers C; Langston A; Graiser M; Plummer T; Lonial S; Waller E -
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Biol Blood Marrow Transplant Volume: 19 Page(s): 460 - 467
03/01/2013 Authors: Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK -
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
J Clin Oncol Volume: 31 Page(s): 794 - 810
02/20/2013 Authors: Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KVI -
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Volume: 19 Page(s): S191 - S191
02/01/2013 Authors: Waller EK; Johnson HR; Jagirdar N; Gaylor C; Lipscomb C; Flowers C; Kaufman J; Khoury HJ; Langston A; Lechowicz M -
A First-in-Disease Trial of in Vivo Costimulation Blockade for GVHD Prevention: The Addition of Abatacept to Standard GVHD Prophylaxis Controls Early CD4+T Cell Proliferation and is Associated with Low Rates of Severe Acute GVHD
Volume: 19 Page(s): S327 - S328
02/01/2013 Authors: Tiwari D; Horan J; Langston A; Qayed M; Carr J; Renfroe H; Couture C; Khoury HJ; Robertson J; Harvey D -
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma.
Transfusion Volume: 53 Page(s): 76 - 84
01/01/2013 Authors: Kaufman JL; Flowers CR; Rados KD; Calandra GB; Vose JM; Hewes LB; Lonial S; Langston AA; Khoury HJ; Lechowicz MJ -
Reanalysis of TransVax immunogenicity.
Lancet Infect Dis Volume: 13 Page(s): 18
01/01/2013 Authors: Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Smith LR; Rolland AP; Kenney RT -
A First-in-Disease Trial of in Vivo Costimulation Blockade for Acute GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Volume: 120
11/16/2012 Authors: Tiwari D; Horan J; Langston A; Qayed M; Carr J; Renfroe H; Cynthia C; Khoury HJ; Jennifer R; Harvey RD -
Consolidation with High Dose Therapy and Autologous Stem Cell Transplant Improves Survival for Patients with Mantle Cell Lymphoma
Volume: 120
11/16/2012 Authors: Nastoupil L; Shenoy PJ; Ambinder A; Seward M; Nooka AK; Waller EK; Langston A; Kaufman JL; King N; Lechowicz MJ -
Impact of Body Mass Index (BMI) On Overall Survival in Myeloma
Volume: 120
11/16/2012 Authors: Kumar M; Nooka AK; Langston A; Gleason C; Watson M; Collins H; Casbourne D; Boise LH; Kaufman JL; Waller EK -
Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry
Volume: 120
11/16/2012 Authors: Hailemichael E; Kaufman JL; Flowers CR; Waller EK; Lechowicz MJ; Langston A; Graiser M; Boise LH; Lonial S; Nooka AK -
Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry
Volume: 120
11/16/2012 Authors: Hailemichael E; Kaufman JL; Flowers CR; Waller EK; Lechowicz MJ; Langston A; Graiser M; Boise LH; Lonial S; Nooka AK -
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
Cancer Volume: 118 Page(s): 5278 - 5282
11/01/2012 Authors: Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ -
A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias.
Cancer Volume: 118 Page(s): 3556 - 3564
07/15/2012 Authors: Khoury HJ; Garcia-Manero G; Borthakur G; Kadia T; Foudray MC; Arellano M; Langston A; Bethelmie-Bryan B; Rush S; Litwiler K -
Efscalefect of lenalidomide, bortezomib, and dexamethasone (RVD) induction therapy in transplant-eligible patients (Pts) with newly diagnosed multiple myeloma (MM) on CR rates and survival.
Volume: 30
05/20/2012 Authors: Gleason C; Nooka AK; Muppidi S; Heffner LT; Steuer CE; Kumar M; Casbourne D; Langston AA; Watson M; Boise L -
CD28-Directed Costimulation Blockade with Abatacept To Prevent GvHD during High-Risk Unrelated BMT: A First-in-Disease Trial
Volume: 12 Page(s): 34 - 34
05/01/2012 Authors: Kean L; Tiwari D; Mehta A; Sen S; Robertson J; Carr J; Renfroe H; Langston A; Waller E; Horan J -
Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection.
Antimicrob Agents Chemother Volume: 56 Page(s): 2652 - 2658
05/01/2012 Authors: Cornely OA; Helfgott D; Langston A; Heinz W; Vehreschild J-J; Vehreschild MJGT; Krishna G; Ma L; Huyck S; McCarthy MC -
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Infect Dis Volume: 12 Page(s): 290 - 299
04/01/2012 Authors: Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Guterwill DF; Smith LR; Rolland AP; Kenney RT -
BI-MODAL AGE DISTRIBUTION OF PATIENTS WITH RELAPSED HODGKIN LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION CORRELATES WITH MARKEDLY INFERIOR SURVIVAL AMONG PATIENTS AGE 35 YEARS AND OLDER
Volume: 18 Page(s): S296 - S296
02/01/2012 Authors: Sharma A; Duan M; Chowdhury R; Graiser M; Zhang H; Langston A; Lonial S; Flowers CR; Haight A; Waller EK -
CD28-DIRECTED T CELL COSTIMULATION BLOCKADE WITH ABATACEPT TO PREVENT GVHD DURING HIGH-RISK UNRELATED HSCT: A FIRST-IN-DISEASE TRIAL
Volume: 18 Page(s): S365 - S365
02/01/2012 Authors: Kean LS; Langston A; Qayed M; Khoury J; Tiwari D; Couture C; Renfroe H; Sen S; Robertson I; Waller EK -
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.
Cancer Volume: 118 Page(s): 428 - 433
01/15/2012 Authors: Arellano M; Winton E; Pan L; Lima L; Tighiouart M; Bhalla K; Heffner LT; Neely J; Hutcherson D; McLemore M -
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.
Am J Health Syst Pharm Volume: 69 Page(s): 149 - 156
01/15/2012 Authors: O'Sullivan AK; Weinstein MC; Pandya A; Thompson D; Langston AA; Perfect JR; Papadopoulos G -
The use of bortezomib in autologous transplantation for multiple myeloma
Milestones in Drug Therapy Volume: 37 Page(s): 69 - 77
12/01/2011 Authors: Langston AA; Lonial S -
A Predictive Model of Overall Survival (OS) for Patients with Relapsed/Refractory Multiple Myeloma (MM) Enrolling in Phase I Clinical Trials
BLOOD Volume: 118 Page(s): 1691 - 1691
11/18/2011 Authors: Nooka AK; Muppidi S; Harvey RD; Kaufman JL; Langston A; Lewis C; Boise LH; Flowers CR; Lonial S -
Temporal Changes in Plerixafor Administration Do Not Impact Hematopoietic Stem Cell Mobilization Efficacy: Results of a Prospective Clinical Trial
Volume: 118 Page(s): 1287 - 1288
11/18/2011 Authors: Harvey RD; Lonial S; Renfroe H; Sinha R; Flowers CR; Lechowicz MJ; Khoury HJ; Langston A; Waller EK; Kaufman JL -
Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)
Volume: 118 Page(s): 707 - 708
11/18/2011 Authors: Sinha R; King N; Shenoy PJ; Lechowicz MJ; Bumpers K; Hutcherson D; Arellano M; Langston A; Kaufman JL; Heffner LT -
The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)
Volume: 118 Page(s): 1709 - 1710
11/18/2011 Authors: Nooka AK; Kaufman JL; Behera M; Gleason C; Langston A; Steuer CE; Flowers CR; Boise LH; Lonial S -
Equivalent Survival Following Fludarabine/Melphalan Reduced Intensity Conditioning with or without Rabbit ATG As Part of GvHD Prophylaxis
Volume: 118 Page(s): 855 - 856
11/18/2011 Authors: Prichard JM; Muppidi S; Flowers CR; Kaufman JL; Lechowicz MJ; Lonial S; Nooka AK; Sinha R; Waller EK; Langston A -
Post-Transplant Platelet Recovery Kinetics and Its Association with Overall Survival in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
Volume: 118 Page(s): 899 - 900
11/18/2011 Authors: Li J; Deppa JA; Ali Z; Graiser M; Langston A; Gleason C; Thomas J; Waller EK -
CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GvHD During High-Risk Unrelated HSCT: A First-in-Disease Feasibility Trial
Volume: 118 Page(s): 1741 - 1742
11/18/2011 Authors: Kean LS; Langston A; Qayad M; Khoury HJ; Tiwari D; Couture C; Renfroe H; Sen S; Robertson J; Waller EK -
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA Volume: 306 Page(s): 1874 - 1883
11/02/2011 Authors: Sorror ML; Sandmaier BM; Storer BE; Franke GN; Laport GG; Chauncey TR; Agura E; Maziarz RT; Langston A; Hari P -
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Transfusion Volume: 51 Page(s): 2175 - 2182
10/01/2011 Authors: Li J; Hamilton E; Vaughn L; Graiser M; Renfroe H; Lechowicz MJ; Langston A; Prichard JM; Anderson D; Gleason C -
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia.
Clin Lymphoma Myeloma Leuk Volume: 11 Page(s): 427 - 432
10/01/2011 Authors: Arellano M; Bernal-Mizrachi L; Pan L; Tighiouart M; Souza L; Guo X; McLemore M; Lima L; Sunay S; Heffner LT -
A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations.
Diagn Microbiol Infect Dis Volume: 71 Page(s): 72 - 80
09/01/2011 Authors: Llata E; Blossom DB; Khoury HJ; Rao CY; Wannemuehler KA; Noble-Wang J; Langston AA; Ribner BS; Lyon GM; Arnold KE -
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica Volume: 96 Page(s): 1113 - 1120
08/01/2011 Authors: Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers MED; Maris MB; Laport GG; Chauncey TR; Lange T -
The economic costs to United States hospitals of invasive fungal infections in transplant patients.
Am J Infect Control Volume: 39 Page(s): e15 - e20
05/01/2011 Authors: Menzin J; Meyers JL; Friedman M; Korn JR; Perfect JR; Langston AA; Danna RP; Papadopoulos G -
Biomarkers of immune activation to screen for severe, acute GVHD.
Bone Marrow Transplant Volume: 46 Page(s): 601 - 604
04/01/2011 Authors: August KJ; Chiang K-Y; Bostick RM; Flanders WD; Waller EK; Langston A; Worthington-White D; Rowland P; Moore KF; Khoury HJ -
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
Blood Volume: 117 Page(s): 3294 - 3301
03/24/2011 Authors: Levis M; Ravandi F; Wang ES; Baer MR; Perl A; Coutre S; Erba H; Stuart RK; Baccarani M; Cripe LD -
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond.
Cancer Volume: 117 Page(s): 1245 - 1252
03/15/2011 Authors: Lima L; Bernal-Mizrachi L; Saxe D; Mann KP; Tighiouart M; Arellano M; Heffner L; McLemore M; Langston A; Winton E -
The use of bortezomib in autologous transplantation for multiple myeloma
Milestones in Drug Therapy Page(s): 69 - 77
12/01/2010 Authors: Langston AA; Lonial S -
Cost-Effectiveness Analysis of a "Just-In-Time" Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant.
Volume: 116 Page(s): 923 - 924
11/19/2010 Authors: Li J; Hamilton E; Vaughn L; Graiser M; Repfroe H; Kaufman JL; Lonial S; Flowers CR; Lechowicz MJ; Langston A -
Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)
Volume: 116 Page(s): 978 - 978
11/19/2010 Authors: Sorror ML; Storer B; Sandmaier BM; Braunert L; Laport GG; Chauncey T; Bredeson C; Maziarz RT; Pulsipher MA; Agura E -
A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables
Volume: 116 Page(s): 1415 - 1416
11/19/2010 Authors: Gyurkocza B; Storb R; Storer BE; Chauncey T; Lange T; Laport GG; Langston A; Pulsipher MA; Bredeson C; Maziarz R -
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Transfusion Volume: 50 Page(s): 2424 - 2431
11/01/2010 Authors: Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ -
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Clin Cancer Res Volume: 16 Page(s): 5079 - 5086
10/15/2010 Authors: Lonial S; Kaufman J; Tighiouart M; Nooka A; Langston AA; Heffner LT; Torre C; McMillan S; Renfroe H; Harvey RD -
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters.
Leuk Lymphoma Volume: 51 Page(s): 1473 - 1477
08/01/2010 Authors: Tran H; Arellano M; Chamsuddin A; Flowers C; Heffner LT; Langston A; Lechowicz MJ; Tindol A; Waller E; Winton EF -
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
J Clin Oncol Volume: 28 Page(s): 2859 - 2867
06/10/2010 Authors: Gyurkocza B; Storb R; Storer BE; Chauncey TR; Lange T; Shizuru JA; Langston AA; Pulsipher MA; Bredeson CN; Maziarz RT -
Safety and efficacy of HiDAC induction in de novo AML patients age 60 and older.
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Arellano ML; Pan L; Lima L; Tighiouart M; Heffner LT; Langston AA; McLemore M; Neely J; Winton EF; Khoury HJ -
Use of posaconazole in the treatment of invasive fungal infections.
Expert Rev Hematol Volume: 2 Page(s): 619 - 630
12/01/2009 Authors: Mehta AK; Langston AA -
Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
Transpl Infect Dis Volume: 11 Page(s): 480 - 490
12/01/2009 Authors: Murali S; Langston A -
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
Volume: 114 Page(s): 325 - 326
11/20/2009 Authors: Levis M; Ravandi F; Wang ES; Baer MR; Perl A; Coutre S; Erba H; Stuart RK; Baccarani M; Cripe LD -
Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.
Volume: 114 Page(s): 478 - 479
11/20/2009 Authors: Hossain MS; Harris WA; Myers SW; Akhtari M; Langston AA; Waller EK -
A Phase 1 Dose-Escalation Study of the Novel KSP Inhibitor ARRY-520 in Advanced Leukemias.
Volume: 114 Page(s): 808 - 808
11/20/2009 Authors: Garcia-Manero G; Khoury HJ; Borthakur G; Ravandi F; Kadia T; Estrov Z; Jabbour E; Foudray MC; Arellano M; Langston A -
Reduced Intensity Conditioning with Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia.
Volume: 114 Page(s): 497 - 498
11/20/2009 Authors: Ram R; Storb RF; Maloney DG; Sandmaier BM; Maris M; Shizuru J; Chauncey T; Langston AA; Georges GE -
A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial
Volume: 114 Page(s): 147 - 147
11/20/2009 Authors: Sandmaier BM; Maris M; Storer B; Vindelov L; Langston A; Wade JC; Bethge WA; Pulsipher M; Lange T; Chauncey T -
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients.
Am J Health Syst Pharm Volume: 66 Page(s): 1711 - 1717
10/01/2009 Authors: Menzin J; Meyers JL; Friedman M; Perfect JR; Langston AA; Danna RP; Papadopoulos G -
Extramedullary acute myeloid leukemia and the use of FDG-PET/CT.
Clin Nucl Med Volume: 34 Page(s): 365 - 366
06/01/2009 Authors: Rao S; Langston A; Galt JR; Halkar RK -
Monitoring chronic myeloid leukemia (CML) response to tyrosine kinase inhibitors (TKI) and homoharringtonine (HHT) using peripheral blood (PB) fluorescence in situ hybridization (FISH) and quantitative RT-PCR (Q-PCR): Are bone marrow biopsies still needed?
Volume: 27
05/20/2009 Authors: Khoury HJ; Lima L; Saxe D; Mann KP; Arellano M; Heffner L; Bernal-Mizrachi L; McLemore M; Langston A; Winton E -
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia (AML)
Volume: 27
05/20/2009 Authors: Arellano ML; Winton E; Pan L; Souza L; Sunay S; Lima L; McLemore M; Heffner LT; Langston A; Khoury HJ -
Monitoring chronic myeloid leukemia (CML) response to tyrosine kinase inhibitors (TKI) and homoharringtonine (HHT) using peripheral blood (PB) fluorescence in situ hybridization (FISH) and quantitative RT-PCR (Q-PCR): Are bone marrow biopsies still needed?
J Clin Oncol Volume: 27 Page(s): 7064
05/20/2009 Authors: Khoury HJ; Lima L; Saxe D; Mann KP; Arellano M; Heffner L; Bernal-Mizrachi L; McLemore M; Langston A; Winton E -
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia (AML).
J Clin Oncol Volume: 27 Page(s): 7070
05/20/2009 Authors: Arellano ML; Winton E; Pan L; Souza L; Sunay S; Lima L; McLemore M; Heffner LT; Langston A; Khoury HJ -
Detection of respiratory viruses with a multiplex polymerase chain reaction assay (MultiCode-PLx Respiratory Virus Panel) in patients with hematologic malignancies.
Leuk Lymphoma Volume: 50 Page(s): 619 - 624
04/01/2009 Authors: Murali S; Langston AA; Nolte FS; Banks G; Martin R; Caliendo AM -
EXTRACORPOREAL PHOTOPHERESIS THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE: RESPONSE IS ASSOCIATED WITH CONTENT OF DENDRITIC CELLS AND T-CELLS IN PERIPHERAL BLOOD AT INITIATION OF TREATMENT
Volume: 15 Page(s): 128 - 129
02/01/2009 Authors: Akhtari M; Giver CR; Renfroe HM; Langston AA; Khoury HJ; Flowers CR; Kaufman JL; Lonial S; Lechowicz MJ; Gleason CL -
PHARMACOKINETIC (PK) COMPARISON OF INTRAVENOUS VERSUS ORAL BUSULFAN CONDITIONING REGIMENS FOR ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS) PATIENTS
Volume: 15 Page(s): 154 - 155
02/01/2009 Authors: Hutcherson DA; Surati M; Sanvidge K; Harvey D; Al-Baldawi RN; Langston A; Flowers C; Lonial S; Kaufman J; Lechowicz MJ -
A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma
CLINICAL LYMPHOMA & MYELOMA Volume: 9 Page(s): S60 - S60
02/01/2009 Authors: Kaufman JL; Lonial S; Sinha R; Torre C; Langston AA; Lechowicz MJ; Flowers C; McMillan S; Renfroe H; Heffner LT -
THE ECONOMIC COSTS TO US HOSPITALS OF INVASIVE FUNGAL INFECTIONS IN HEMATOPOIETIC STEM CELL AND BONE MARROW TRANSPLANT PATIENTS
Volume: 15 Page(s): 7 - 7
02/01/2009 Authors: Menzin J; Jackel JL; Friedman M; Korn JR; Perfect J; Langston A; Prasasd M; Papadopoulos G -
Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients.
Bone Marrow Transplant Volume: 43 Page(s): 155 - 158
01/01/2009 Authors: Akhtari M; Langston AA; Waller EK; Gal AA -
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States.
Value Health Volume: 12 Page(s): 666 - 673
01/01/2009 Authors: O'Sullivan AK; Pandya A; Papadopoulos G; Thompson D; Langston A; Perfect J; Weinstein MC -
Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.
J Antimicrob Chemother Volume: 62 Page(s): 1386 - 1391
12/01/2008 Authors: Hachem RY; Langston AA; Graybill JR; Perfect JR; Pedicone LD; Patino H; Raad II -
A Randomized Phase I Trial of Melphalan plus Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration
Volume: 112 Page(s): 1144 - 1145
11/16/2008 Authors: Lonial S; Kaufman J; Torre C; Langston A; Lechowicz MJ; Flowers C; McMillan S; Renfroe H; Heffner LT; Waller EK -
Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease
Volume: 112 Page(s): 432 - 432
11/16/2008 Authors: Giver CR; Akhtari M; Langston AA; Khoury HJ; Flowers CR; Kaufman JL; Lonial S; Lechowicz MJ; Gleason CL; Vaughn ML -
Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study
Volume: 112 Page(s): 1247 - 1247
11/16/2008 Authors: Langston AA; Murali S; McMillan S; Heffner LT; Lonial S; Waller EK; Flowers CR; Kaufman J; McLemore ML; Sinha R -
Copper Deficiency Remains An Underappreciated Cause of Ineffective Hematopoiesis
Volume: 112 Page(s): 1062 - 1062
11/16/2008 Authors: Langston A; Neely J; Heffner L; Griffith D; Arellano M; Esper G; McLemore ML; Ziegler T; Kempton C; Sinha R -
Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged >= 60 Years
Volume: 112 Page(s): 753 - 754
11/16/2008 Authors: Sorror ML; Storer B; Sandmaier BM; Maloney DG; Franke G; Shizuru J; Chauncey T; Agura E; Maziarz RT; Sahebi F -
Sustained Graft-Versus-Lymphoma Effect among Patients (pts) with Mantle Cell Lymphoma (MCL) Given Nonmyeloablative, Allogeneic Hematopoictic Cell Transplantation (HCT).
Volume: 112 Page(s): 747 - 748
11/16/2008 Authors: Sorror ML; Storer B; Sandmaier BM; Maris M; Chauncey T; Maziarz RT; Pulsipher M; Shizuru J; Niederwieser D; Agura E -
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients with De Novo and Secondary Acute Myeloid Leukemia
Volume: 112 Page(s): 61 - 61
11/16/2008 Authors: Gyurkocza B; Storb RF; Storer B; Chauncey T; Niederwieser D; Shizuru J; Langston A; Pulsipher M; Bredeson C; Maziarz RT -
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
J Clin Oncol Volume: 26 Page(s): 4912 - 4920
10/20/2008 Authors: Sorror ML; Storer BE; Sandmaier BM; Maris M; Shizuru J; Maziarz R; Agura E; Chauncey TR; Pulsipher MA; McSweeney PA -
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
Bone Marrow Transplant Volume: 42 Page(s): 529 - 534
10/01/2008 Authors: Murali S; Winton E; Waller EK; Heffner LT; Lonial S; Flowers C; Kaufman J; Arellano M; Lechowicz MJ; Mann KP -
The prognostic significance of donor dendritic cells in allogeneic hematopoietic progenitor cell transplant
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Dejoubner N; Ali Z; Grasier M; Hamilton E; Flowers C; Lonial S; Langston A; Waller EK -
Induction of GvL after allogeneic stem cell transplantation
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Arellano ML; Harris W; Langston A; McMillan S; Rosenthal H; Waller EK -
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer Volume: 112 Page(s): 1992 - 2001
05/01/2008 Authors: Sorror M; Storer B; Sandmaier BM; Maloney DG; Chauncey TR; Langston A; Maziarz RT; Pulsipher M; McSweeney PA; Storb R -
EARLY DETECTION OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE USING PLASMA MARKERS OF T-CELL ACTIVATION
Volume: 14 Page(s): 133 - 133
02/01/2008 Authors: August KJ; Chiang K-J; Bostick RM; Waller EK; Langston A; Khoury HJ; Moore KF; Worthington-White D; Rowland P; Horan JT -
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
J Clin Oncol Volume: 26 Page(s): 211 - 217
01/10/2008 Authors: Rezvani AR; Storer B; Maris M; Sorror ML; Agura E; Maziarz RT; Wade JC; Chauncey T; Forman SJ; Lange T -
Epidemiology of Multiple Myeloma
Page(s): 9 - 22
01/01/2008 Authors: Langston AA; Francis D -
Therapeutic drug monitoring (TDM) of IV busulfan in patients with severe obesity
Volume: 110 Page(s): 592A - 592A
11/16/2007 Authors: Hutcherson DA; Sessions JK; Mihelic RA; Sanvidge K; Stricker SR; Langston A; Flowers C; Lechowicz MJ; Waller N; Lonial S -
The effect of rituximab on mobilization with AMD3100 plus G-CSF in patients with relapsed or refractory NHL or HD
Volume: 110 Page(s): 568A - 568A
11/16/2007 Authors: Kaufman JL; Cook AM; Flowers C; Langston AA; Lonial S; Lechowicz MJ; Khoury HJ; Calandra G; Waller N -
A randomized phase I trial of Melphalan plus Bortezomib as conditioning for autologous transplant for myeloma: The effect of sequence of administration
Volume: 110 Page(s): 288A - 289A
11/16/2007 Authors: Lonial S; Kaufman J; Langston A; Heffner LT; Torre C; Lechowicz MJ; Flowers C; McMillan S; Arnold M; Waller NK -
Patulin, a mycotoxin, has potent cytotoxic activity on actue lymphoblastic leukemia and induce apoptosis through intrinsic and extrinsic pathways
Volume: 110 Page(s): 151B - 152B
11/16/2007 Authors: Wang F; David E; Lonial S; Arellano M; Khoury HJ; Langston A; Lechowicz MJ; Waller N -
Cost-effectiveness of posaconazole vs fluconazole in the prevention of invasive fungal infections among patients with graft-versus-host disease (GVHD) in the US
Volume: 110 Page(s): 979A - 979A
11/16/2007 Authors: O'Sullivan AK; Weirstein MC; Pandya A; Thompson D; Langston A; Perfect J; Papadopoulos G -
Long-term follow up of patients (pts) with high-risk chronic lymphocytic leukemia (CLL) given nonmyeloablative allogeneic hematopoietic cell transplantation (HCT)
Volume: 110 Page(s): 496A - 496A
11/16/2007 Authors: Sorror ML; Storer B; Sandmaier BM; Maris MB; Shizuru J; Leis J; Agura E; Chauncey T; Pulsipher M; McSweeney P -
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood Volume: 110 Page(s): 2744 - 2748
10/01/2007 Authors: Kahl C; Storer BE; Sandmaier BM; Mielcarek M; Maris MB; Blume KG; Niederwieser D; Chauncey TR; Forman SJ; Agura E -
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biol Blood Marrow Transplant Volume: 13 Page(s): 1041 - 1048
09/01/2007 Authors: Baron F; Sandmaier BM; Storer BE; Maris MB; Langston AA; Lange T; Petersdorf E; Bethge W; Maziarz RT; McSweeney PA -
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience.
Biol Blood Marrow Transplant Volume: 13 Page(s): 746 - 747
06/01/2007 Authors: Santos EC; Sessions J; Hutcherson D; Flowers C; Langston A; Waller EK -
Bortezomib,thalidomide and dexamethasone as induction
Volume: 92 Page(s): 181 - 181
06/01/2007 Authors: Kaufman JL; Gleason C; Heffner LT; Langston AA; Waller EK; Lonial S -
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
Blood Volume: 109 Page(s): 4548 - 4556
05/15/2007 Authors: Hossain MS; Roback JD; Pollack BP; Jaye DL; Langston A; Waller EK -
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. (vol 47, pg 629, 2007)
TRANSFUSION Volume: 47 Page(s): 952 - 952
05/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi SS; Teagarden D; Hamilton ES; Waller EK -
Erratum: Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells (Transfusion (2007) 47, 4, (629-635))
Transfusion Volume: 47 Page(s): 952
05/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK -
Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.
J Clin Microbiol Volume: 45 Page(s): 1648 - 1651
05/01/2007 Authors: Ferguson TD; Schniederjan SD; Dionne-Odom J; Brandt ME; Rinaldi MG; Nolte FS; Langston A; Zimmer SM -
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
Transfusion Volume: 47 Page(s): 629 - 635
04/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK -
Posaconazole prophylaxis in haematopoietic stem cell transplant recipients and neutropenic patients: Pharmacokinetics and safety analysis
Volume: 39 Page(s): S165 - S165
04/01/2007 Authors: Maertens J; Langston A; Ullmann A; Cornely O; Lipton J; Winston D; Perfect J; Chandrasekar P; Brundage T; Patino H -
A randomized phase I trial of melphalan plus bortezomib as conditioning for autologous transplant for myeloma: The effect of sequence of administration
Volume: 13 Page(s): 56 - 56
02/01/2007 Authors: Lonial S; Kaufman J; Langston AA; Khoury HJ; Torre C; Lechowicz MJ; Flowers C; Waller EK -
Impact of posaconazole (POS) vs fluconazole (FLU) on cyclosporine (CSA) and tacrolimus (TAC) dosing in hematopoietic stem cell transplant (HSCT) recipients with graft-vs-host disease (GVHD)
Volume: 13 Page(s): 76 - 76
02/01/2007 Authors: Langston A; Lipton JH; Brundage T; Patino H; Ullmann AJ -
Longer follow up of patients (PTS) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)
Volume: 13 Page(s): 133 - 134
02/01/2007 Authors: Sorror ML; Storer B; Sandmaier BM; Maris MB; Shizuru J; Niederwieser D; Agura E; Chauncey T; Maziarz R; Pulsipher M -
Incidence and mortality of invasive fungal infections in high-risk patients receiving posaconazole versus fluconazole or itraconazole prophylaxis
Volume: 13 Page(s): 33 - 33
02/01/2007 Authors: Langston A; Lipton JH; Comely OA; Ullnumn AJ; Patino H; Hardalo C; Winston DJ; Chandnisekar P -
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
N Engl J Med Volume: 356 Page(s): 335 - 347
01/25/2007 Authors: Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N -
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Biol Blood Marrow Transplant Volume: 13 Page(s): 116 - 123
01/01/2007 Authors: Arellano ML; Langston A; Winton E; Flowers CR; Waller EK -
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Clin Infect Dis Volume: 44 Page(s): 2 - 12
01/01/2007 Authors: Walsh TJ; Raad I; Patterson TF; Chandrasekar P; Donowitz GR; Graybill R; Greene RE; Hachem R; Hadley S; Herbrecht R -
Tolerability and anti-leukemic activity of ara-C, topotecan, and gemtuzumab ozogamicin [ATGO] in advanced MDS and AML: Interim analysis of phase I/II data.
Volume: 108 Page(s): 554A - 554A
11/16/2006 Authors: Murali S; Winton EF; McMillan S; Lonial S; Waller N; Heffner L; Flowers C; Kaufman JL; Lechowicz MJ; Khoury HJ -
Patients receiving patifermin in conjunction with melphalan 200 required fewer platelet transfusions: Analysis of a retrospective cohort study.
Volume: 108 Page(s): 407B - 407B
11/16/2006 Authors: Hutcherson DA; Langston A; Lin CH; Flowers C; Lechowicz MJ; Waller N; Sessions JK; Kaufman JL; Jean Khoury H; Lonial S -
Impact of revised international working group criteria on lymphoma patients undergoing autologous stem cell transplantation.
Volume: 108 Page(s): 873A - 873A
11/16/2006 Authors: Lucas AS; Flowers C; Langston A; Lonial S; Lechowicz MJ; Waller N; Kaufman JL; Jean Khoury H -
T cell reconstitution in first 200 days post transplantation predicts long term survival in allogeneic hematopoetic progenitor cell transplantation (HPCT).
Volume: 108 Page(s): 920A - 920A
11/16/2006 Authors: Vann L; Larks M; Flowers C; Lonial S; Kaufman J; Lechowicz MJ; Langston AA; Khoury J; Waller N -
Infliximab for the treatment of chronic graft versus host disease.
Volume: 108 Page(s): 818A - 818A
11/16/2006 Authors: Tolbert E; Waller N; Khoury HJ; Lechowicz MJ; Flowers C; Lonial S; Vann L; Langston A; Kaufman JL -
A randomized trial to evaluate the impact of cytokines (G-CSF or GM plus G-CSF) on dendritic cell and T-Cell content and function when mobilizing normal donors for allogeneic progenitor cell transplant.
Volume: 108 Page(s): 964A - 964A
11/16/2006 Authors: Lonial S; McMillan S; Torre C; Langston AA; Hamilton E; Cook A; Flowers C; Kaufman JL; Lechowicz MJ; Waller N -
Deep venous thromboses associated with peripherally inserted central catheters in patients with hematological malignancies.
Volume: 108 Page(s): 226B - 226B
11/16/2006 Authors: Tran H; Chamsuddin A; Winton EF; Heffner L; Langston A; Waller N; Arellano M; Khoury HJ -
Postgrafting immunosuppression with prolonged mycophenolate mofetil (MMF) and truncated cyclosporine (CSP) failed to reduce the incidence of graft-versus-host disease (GVHD) after unrelated donor hematopoietic cell transplantation (HCT) with nonmyeloablative conditioning.
Volume: 108 Page(s): 889A - 889A
11/16/2006 Authors: Baron F; Sandmaier BM; Storer B; Maris M; Langston A; Niederwieser DW; Petersdorf E; Bethge W; Maziarz RT; McSweeney P -
The joint role of comorbidity and performance status (PS) in predicting morbidity after allogeneic nonmyeloablative hematopoietic cell transplantation (HCT).
Volume: 108 Page(s): 180A - 180A
11/16/2006 Authors: Sorror M; Storer B; Sandmaier BM; Maloney DG; Pulsipher M; Langston A; Maris MB; Niederwieser D; Storb R -
Cost-effectiveness of posaconazole versus standard azole therapy in the prevention of invasive fungal infections among high-risk neutropenic patients in the US
Volume: 108 Page(s): 945A - 945A
11/16/2006 Authors: O'Sullivan AK; Pandya A; Thompson D; Papadopoulos G; Weinstein MC; Perfect JR; Langston A -
Outcomes of allogeneic hematopoietic stem cell transplantation (HCT) after non-myeloablative conditioning in relapsed, refractory, or transformed indolent non-hodgkin lymphoma (NHL).
Volume: 108 Page(s): 891A - 891A
11/16/2006 Authors: Rezvani AR; Sandmaier BM; Storer B; Maris M; Agura E; Maziarz R; Wade JC; Chauncey T; Forman SJ; Niederwieser DW -
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Leuk Lymphoma Volume: 47 Page(s): 2155 - 2162
10/01/2006 Authors: Lonial S; Arellano M; Hutcherson D; Langston A; Flowers C; Heffner LT; Winton E; Jo Lechowicz M; Waller EK -
A randomized phase I trial of melphalan + bortezomib as conditioning for autologous transplant for myeloma.
J Clin Oncol Volume: 24 Page(s): 17550
06/20/2006 Authors: Kaufman JL; Waller EK; Torre C; McMillan S; Langston A; Flowers C; Lechowicz M; Tighiouart M; Lonial S -
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
Clin Infect Dis Volume: 42 Page(s): 1726 - 1734
06/15/2006 Authors: Raad II; Graybill JR; Bustamante AB; Cornely OA; Gaona-Flores V; Afif C; Graham DR; Greenberg RN; Hadley S; Langston A -
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Arthritis Rheum Volume: 54 Page(s): 1982 - 1986
06/01/2006 Authors: Nash RA; McSweeney PA; Nelson JL; Wener M; Georges GE; Langston AA; Shulman H; Sullivan KM; Lee J; Henstorf G -
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Cancer Volume: 106 Page(s): 2171 - 2180
05/15/2006 Authors: Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S -
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biol Blood Marrow Transplant Volume: 12 Page(s): 454 - 465
04/01/2006 Authors: Maris MB; Sandmaier BM; Storer BE; Maloney DG; Shizuru JA; Agura E; Kliem C; Pulsipher M; Maziarz RT; McSweeney PA -
Reduced-intensity conditioning permits a significant graft vs leukemia (GvL) effect for acute leukemia
Volume: 12 Page(s): 69 - 70
02/01/2006 Authors: Arellano M; Flowers C; Waller E; Lonial S; Kaufman J; Winton E; Khoury H; Langston A -
Idiopathic secondary post-transplant thrombocytopenia (ISPT) following autologous hematopoietic progenitor cell transplantation (HPCT) is associated with transplantation of lower numbers of primitive hematopoietic progenitors
Volume: 12 Page(s): 132 - 132
02/01/2006 Authors: Ninan MJ; Arellano M; Philip A; Langston A; Flowers CR; Lonial S; Kaufman J; Lechowicz M; Khoury JH; Roback J -
Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): A multicenter trial
Volume: 12 Page(s): 134 - 134
02/01/2006 Authors: Durrant S; Vesole D; Langston A; Lipton JH; Patino H; Pedicone L; Ullmann AJ -
Posaconazole as salvage therapy for zygomycosis.
Antimicrob Agents Chemother Volume: 50 Page(s): 126 - 133
01/01/2006 Authors: Greenberg RN; Mullane K; van Burik J-AH; Raad I; Abzug MJ; Anstead G; Herbrecht R; Langston A; Marr KA; Schiller G -
Relapse free survival of elderly AML patients is comparable to that of younger adults when treated with a modified dose intensive cytarabine regimen.
Volume: 106 Page(s): 237B - 237B
11/16/2005 Authors: Langston AA; Heffner LT; Hutcherson D; Neely J; Flowers C; Waller EK; Lonial S; Khoury HJ; Winton E -
Decreased incidence of relapse in patients with acute leukemia transplanted from matched unrelated donors: Induction of GvL
Volume: 106 Page(s): 570A - 571A
11/16/2005 Authors: Arellano ML; Langston A; Lonial S; Flowers C; Khoury JH; Winton E; Waller EK; Mary LJ -
A randomized trial to evaluate the impact of cytokines (G-CSF or GM plus GCSF) on dendritic cell and T-cell content and function when mobilizing normal donors for allogeneic progenitor cell transplant
Volume: 106 Page(s): 555A - 555A
11/16/2005 Authors: Lonial S; Torre C; Langston AA; McMillans S; Hamilton E; Flowers C; Lechowicz MJ; Waller EK -
Patient characteristics in CD 20(+) and CD 20(-) adult acute lymphoblastic leukemia (ALL): A single institution analysis.
Volume: 106 Page(s): 210B - 210B
11/16/2005 Authors: Gladney SP; Heffner LT; Langston A; Holden J; Phillips C; Winton E; Flowers CR; Lechowicz MJ; Lonial S; Waller E -
Prognostic significance of early peripheral blood blasts clearance following induction chemotherapy for adult acute myeloid leukemia.
Volume: 106 Page(s): 236B - 236B
11/16/2005 Authors: Pakkala S; Winton E; Langston A; Heffner LT; Khoury HJ -
Allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning for relapsed or refractory follicular lymphoma.
Volume: 106 Page(s): 329A - 329A
11/16/2005 Authors: Maris MB; Sandmaier BM; Storer B; Agora E; Wade J; Maziarz RT; Forman S; Shizuru J; Chauncey T; Kahl C -
Efficacy and safety of posaconazole (POS) in the treatment of refractory invasive fungal infections (rIFIs) in patients with underlying renal impairment.
Volume: 106 Page(s): 430B - 430B
11/16/2005 Authors: Langston AA; Graham DR; Graybill JR; Pedicone LD; Raad II -
Hematopoietic cell transplants (HCT) from HLA-matched related (MRD) and unrelated (URD) donors for patients with hematologic malignancies using low-dose TBI conditioning.
Volume: 106 Page(s): 194A - 194A
11/16/2005 Authors: Sandmaier BM; Maris MB; Maloney DG; Gooley TA; Shizuru JA; Niederwieser DW; Chauncey TR; Sahebi F; Agura E; Maziarz RT -
Efficacy of nonmyeloablative hematopoietic cell transplant (HCT) in secondary myelodysplastic syndrome (MDS) and its impact on the primary disease.
Volume: 106 Page(s): 234A - 234A
11/16/2005 Authors: Kerbauy F; Maris M; Storer B; Maloney D; Niederwieser D; Agura E; Pulsipher M; Chauncey T; Maziarz R; Forman S -
Results of a clinical phase I dose-escalation study of cylarabine in combination with fixed dose vinorelbine, paclitaxel, etoposide, and cisplatin (VTEPA) for the treatment of relapsed/refractory lymphoma.
Volume: 23 Page(s): 607S - 607S
06/01/2005 Authors: Arellano ML; Lonial S; Langston A; Flowers C; Heffner T; Hutcherson D; Winton E; Waller E -
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
J Clin Oncol Volume: 23 Page(s): 3819 - 3829
06/01/2005 Authors: Sorror ML; Maris MB; Sandmaier BM; Storer BE; Stuart MJ; Hegenbart U; Agura E; Chauncey TR; Leis J; Pulsipher M -
Rituximab does not inhibit chemo-mobilization of HPC or engraftment following autologous transplant for lymphoma
Volume: 11 Page(s): 6 - 6
02/01/2005 Authors: Kaufman JL; Lonial S; Hicks M; Langston A; Flowers C; Lechowicz MJ; Khoury H; Waller EK -
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Biol Blood Marrow Transplant Volume: 10 Page(s): 848 - 857
12/01/2004 Authors: Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK -
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood Volume: 104 Page(s): 3535 - 3542
12/01/2004 Authors: Maris MB; Sandmaier BM; Storer BE; Chauncey T; Stuart MJ; Maziarz RT; Agura E; Langston AA; Pulsipher M; Storb R -
A phase I trial of ara-C, topotecan, and gemtuzumab ozogamicin (Mylotarg (R)) for advanced MDS and secondary or relapsed AML.
Volume: 104 Page(s): 502A - 502A
11/16/2004 Authors: Langston AA; McMillan S; Lonial S; Smith K; Waller EK; Heffner LT; Bucur S; Redei I; Flowers C; Lechowicz MJ -
A randomized trial to evaluate the impact of cytokines on dendritic cell, T-cell and T-cell function when mobilizing normal donors for allogeneic progenitor cell transplant: An interim analysis.
Volume: 104 Page(s): 780A - 780A
11/16/2004 Authors: Lonial S; Torre C; Hicks M; Mcmillan S; Langston AA; Flowers CR; Lechowicz MJ; Waller EK -
Predictors of more rapid lymphoid reconstitution after allogeneic transplantation
Volume: 104 Page(s): 864A - 864A
11/16/2004 Authors: Arellano ML; Moore SG; Kudchadkar R; Flowers CR; Langston AA; Lonial S; Lechowicz MJ; Waller EK -
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
Volume: 104 Page(s): 231A - 231A
11/16/2004 Authors: Maris MB; Sandmaier BM; Storer BE; Chauncey T; Stuart MJ; Maziarz RT; Agura E; Langston AA; Pulsipher M; Storb R -
Nonmyeloablative conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related or unrelated donors for chemotherapy-refractory chronic lymphocytic leukemia (CLL).
Volume: 104 Page(s): 639A - 639A
11/16/2004 Authors: Sorror M; Maris M; Storer B; Sandmaier B; Stuart M; Hegenbart U; Agura E; Chauncey T; Leis J; Pulsipher M -
Unrelated donor peripheral blood stem cell (PBSC) transplantation using nonmyeloablative conditioning and mycophenolate mofetil (MMF) TID results in high engraftment rates.
Volume: 104 Page(s): 503A - 503A
11/16/2004 Authors: Maris MB; Sandmaier BM; Storer B; Shizuru J; Maloney D; Agura E; Niederwieser D; Pulsipher M; Maziarz RT; McSweeney P -
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Volume: 33 Page(s): 196 - 197
11/01/2004 Authors: Waller E; Giver C; Somani J; Langston A; Lonial S; Roback J; Jian ML; Hossain M; Redei I -
Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults.
Semin Oncol Volume: 31 Page(s): 80 - 86
04/01/2004 Authors: Winton EF; Langston AA -
Update on myelodysplastic syndromes: new approaches to classification and therapy.
Semin Oncol Volume: 31 Page(s): 72 - 79
04/01/2004 Authors: Langston AA; Walling R; Winton EF -
Update in acute leukemia 2003: A risk adapted approach to acute myeloblastic leukemia in adults
Volume: 31 Page(s): 80 - 86
04/01/2004 Authors: Winton EF; Langston AA -
Update on myelodysplastic syndromes: New approaches to classification and therapy
Volume: 31 Page(s): 72 - 79
04/01/2004 Authors: Langston AA; Walling R; Winton EF -
Optimization of chemo-mobilization of autologous blood hematopoietic progenitor cell grafts
Volume: 10 Page(s): 64 - 65
02/01/2004 Authors: Hicks ML; Lonial S; Langston A; Smith KJ; Sai SM; Hamilton ES; Waller EK -
Retrospective review of therapy with reduced dose rasburicase in adults with hyperuricemia associated with malignancy
Volume: 10 Page(s): 104 - 104
02/01/2004 Authors: Hutcherson DA; Sessions JK; Mihelic RA; Shayani S; Barreras AM; Bucur SZ; Heffner LT; Langston AA -
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Blood Cells Mol Dis Volume: 33 Page(s): 233 - 237
01/01/2004 Authors: Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li J-M; Hossain MS; Redei I -
Update on Myelodysplastic Syndromes: New Approaches to Classification and Therapy
Volume: 31 Page(s): 72 - 79
01/01/2004 Authors: Langston AA; Walling R; Winton EF -
Update in Acute Leukemia 2003: A Risk Adapted Approach to Acute Myeloblastic Leukemia in Adults
Volume: 31 Page(s): 80 - 86
01/01/2004 Authors: Winton EF; Langston AA -
Optimal timing for chemotherapy and cytokine mobilization of autologous blood hematopoietic progenitor cells.
Volume: 102 Page(s): 419B - 419B
11/16/2003 Authors: Hicks ML; Lonial S; Langston A; Smith KJ; Sai SM; Hamilton ES; Waller EK -
A phase I study of dose escalated cytarabine in combination with a modified ESHAP-like regimen, paclitaxel, and vinorelbine (VTEPA) for the treatment of relapsed/refractory lymphoma.
Volume: 102 Page(s): 293B - 293B
11/16/2003 Authors: Lonial S; Tanner A; Langston AA; Redei I; Heffner LT; Bucur SZ; Hutcherson D; Winton E; Waller EK -
Early autologous transplantation for mantle cell lymphoma may improve long term disease-free survival.
Volume: 102 Page(s): 734A - 735A
11/16/2003 Authors: Murali S; Lonial S; Redei I; Smith K; Waller EK; Heffner LT; Bucur S; Winton E; Manion K; Langston A -
Modulation of allogeneic PBPC graft contents using G-CSF or G-CSF+GM-CSF: Preliminary results from a randomized trial.
Volume: 102 Page(s): 953A - 953A
11/16/2003 Authors: Lonial S; Torre C; Hicks M; Tanner A; Langston AA; Redei I; Waller EK -
Safety of voriconazole after autologous and allogeneic stem cell transplantation.
Volume: 102 Page(s): 454B - 454B
11/16/2003 Authors: Restrepo MH; Langston AA; Shayani S; Waller EK; Lonial S -
A phase I trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg (R)) for advanced MDS and secondary or relapsed AML.
Volume: 102 Page(s): 333B - 333B
11/16/2003 Authors: Langston AA; Tanner A; Lonial S; Heffner LT; Smith K; Bucur S; Waller EK; Redei I; Winton E -
Posaconazole for treatment of invasive aspergillosis in patients who are refractory to or intolerant of conventional therapy: An externally controlled blinded trial.
Volume: 102 Page(s): 195A - 196A
11/16/2003 Authors: Walsh T; Patterson T; Langston A; van Burik J; Louie A; Herbrecht R; Hadley S; Perfect J; Hsu C; Gogate J -
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.
Biol Blood Marrow Transplant Volume: 9 Page(s): 460 - 471
07/01/2003 Authors: Waller EK; Langston AA; Lonial S; Cherry J; Somani J; Allen AJ; Rosenthal H; Redei I -
Three methods of T-cell depletion of HPCT products: Analysis of CD34+ cell and lymphocyte purity and recovery.
Volume: 100 Page(s): 835A - 836A
11/16/2002 Authors: Lonial S; Rizzieri DA; Koh LP; Jones M; Langston AA; Redei I; Long GD; Gasparetto C; Vredenburgh JJ; Waller EK -
Effect of donor dendritic cells on overall survival and incidence of GvHD after allogeneic HPCT from HLA matched sibling donors.
Volume: 100 Page(s): 420A - 421A
11/16/2002 Authors: Gladney SP; Waller EK; Redei I; Langston AA; Lonial S -
Therapy with thalidomide enhances overall survival after autologous PBSC transplant for multiple myeloma.
Volume: 100 Page(s): 178A - 178A
11/16/2002 Authors: Brinker B; Waller EK; Langston AA; Redei I; Smith KJ; Bucur SZ; Winton E; Lyles R; Heffner LT; Lonial S -
Treatment of severe systemic sclerosis with allogenic marrow transplantation.
Volume: 100 Page(s): 460B - 461B
11/16/2002 Authors: Nash RA; McSweeney PA; Storb R; Sullivan KM; Langston A; Sunderhaus JL; Wener M; Furst D -
Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
Bone Marrow Transplant Volume: 30 Page(s): 335 - 340
09/01/2002 Authors: Redei I; Langston AA; Lonial S; Cherry JK; Allen AJ; Hamilton E; Jones M; Bartlett VM; Waller EK -
Haploindentical transplantion for adults with poor prognostic hematologic malignancies using the Perugia approach.
LEUKEMIA Volume: 16 Page(s): 414 - 414
03/01/2002 Authors: Redei I; Langston AA; Cherry J; Allen A; Bartlett V; Waller EK -
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
Blood Volume: 99 Page(s): 1085 - 1088
02/01/2002 Authors: Langston AA; Redei I; Caliendo AM; Somani J; Hutcherson D; Lonial S; Bucur S; Cherry J; Allen A; Waller EK -
Granulomatous Pneumocystis carinii pneumonia complicating hematopoietic cell transplantation.
Pathol Res Pract Volume: 198 Page(s): 553 - 558
01/01/2002 Authors: Gal AA; Plummer AL; Langston AA; Mansour KA -
Salvage therapy with Infliximab for patients with severe acute and chronic GvHD.
BLOOD Volume: 98 Page(s): 399A - 399A
11/16/2001 Authors: Redei I; Knoche J; Tanner AR; Langston AA; Lonial S; Cherry JK; Sai SM; Waller EK -
Comparison of partially mismatched related donor (PMRD) graft vs volunteer unrelated donor (VUD) transplant for high risk hematologic malignancies.
BLOOD Volume: 98 Page(s): 386B - 386B
11/16/2001 Authors: Redei I; Langston AA; Jones M; Tanner A; Teagarden D; Lonial S; Cherry J; Bartlett V; Waller EK -
Yield of surveillance blood cultures in patients on corticosteroids for graft-versus-host disease.
BLOOD Volume: 98 Page(s): 362B - 362B
11/16/2001 Authors: Somani J; Teagarden D; Mossavi-sai S; Thourani J; Redei I; Lonial S; Waller EK; Langston AA -
CD34 selection of peripheral blood progenitor cells for autologous transplant in myeloma and amyloidosis is associated with an increased risk of post-transplant varicella Zoster.
BLOOD Volume: 98 Page(s): 392A - 392A
11/16/2001 Authors: Smith KJ; Hamilton ES; Waller EK; Langston AA; Redei I; Lonial S; Heffner LT -
Infectious outcomes after alternative donor stem cell transplantation: A retrospective cohort study.
BLOOD Volume: 98 Page(s): 205A - 205A
11/16/2001 Authors: Somani J; Redei I; Cherry J; Tanner A; Lonial S; Bartlett V; Manion K; Waller EK; Langston AA -
Non-fatal Veno-Occlusive disease in non-transplant patients after treatment of relapsed AML with Mylotarg (gemtuzumab ozogamicin).
BLOOD Volume: 98 Page(s): 201B - 202B
11/16/2001 Authors: Langston AA; Feinstein B; Hutcherson D; Heffner LT; Redei I; Smith K; Lonial S; Bucur S; Jones A; Waller EK -
Thymoglobulin pharmicokinetics and immune reconstitution in recipients of T-cell depleted CD34+transplants from HLA mis-matched donors.
BLOOD Volume: 98 Page(s): 670A - 670A
11/16/2001 Authors: Waller N; Langston A; Lonial S; Allen A; Cherry J; Rosenthal HS; Redei I -
Busulfan/cyclopliospliamide/fludarabine/ATG conditioning permits engraftment for patients receiving CD34+T-cell depleted transplants from partially matched related donors (PMRD).
BLOOD Volume: 98 Page(s): 386B - 386B
11/16/2001 Authors: Redei I; Langston AA; Lonial S; Cherry JK; Allen AJ; Manion K; Hamilton ES; Bartlett V; Waller EK -
Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.
Blood Volume: 97 Page(s): 2948 - 2956
05/15/2001 Authors: Waller EK; Rosenthal H; Jones TW; Peel J; Lonial S; Langston A; Redei I; Jurickova I; Boyer MW -
Chronic GVHD (cGVHD) after matched sibling BMT is predicted by the number of transplanted donor NK-like T cells
Blood Volume: 96
12/01/2000 Authors: Langston A; Jones TW; Rosenthal H; Redei I; Lonial S; Waller EK -
Sequential CD34+and CD3+allogeneic cell transplants in patients with poor risk hematologic malignancies.
BLOOD Volume: 96 Page(s): 359B - 359B
11/16/2000 Authors: Waller EK; Langston AA; Bucur S; Lonial S; Cherry J; Feinstein B; Redei I -
Chronic GVHD (cGVHD) after matched sibling BMT is predicted by the number of transplanted donor NK-like T cells.
BLOOD Volume: 96 Page(s): 200A - 200A
11/16/2000 Authors: Langston A; Jones TW; Rosenthal H; Redei I; Lonial S; Waller EK -
Modified perugia approach for haploindentical related donor transplantation for adults with poor prognostic hematologc malignancies.
BLOOD Volume: 96 Page(s): 209A - 209A
11/16/2000 Authors: Redei I; Langston AA; Cherry JK; Allen AJ; Bartlett VM; Waller EK -
Effective T cell depletion of G-CSF mobilized haploidentical PBSC graft with combined positive/negative immunomagnetic selection using Isolex 300i system version 2.5.
BLOOD Volume: 96 Page(s): 185A - 185A
11/16/2000 Authors: Redei I; Langston AA; Cherry JK; Hamilton ES; Jones ML; Waller EK -
Acyclovir (ACV)-resistant herpes simplex virus (HSV) after T- and B-cell depleted haploidentical stem cell transplantation (SCT).
BLOOD Volume: 96 Page(s): 193A - 193A
11/16/2000 Authors: Langston A; Redei I; Bucur S; Cherry J; Allen A; Thourani J; Teagarden D; Mossavi-Sai S; Hutcherson D; Waller EK -
Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature.
Bone Marrow Transplant Volume: 24 Page(s): 1337 - 1341
12/01/1999 Authors: Lonial S; Bilodeau PA; Langston AA; Lewis C; Mossavi-Sai S; Holden JT; Waller EK -
Modified high dose Ara-C (mHiDAC) and daunorubicin as induction therapy for newly diagnosed AML without t(15;17).
BLOOD Volume: 94 Page(s): 233B - 233B
11/15/1999 Authors: Lonial S; Langston AA; Bhalla K; Smith KJ; Heffner LT; Bucur S; Hutcherson DA; Winton EF -
Survival analysis of allogeneic bone marrow transplant (BMT) with and without GM-CSF support, a retrospective analysis of 182 patient.
BLOOD Volume: 94 Page(s): 151A - 151A
11/15/1999 Authors: Lonial S; Langston AA; Jones TW; Ennis SD; Waller EK -
Autologous peripheral blood stem cell (PBSC) transplantation in AML: Outcome and flow cytometric analysis of the PBSC product.
BLOOD Volume: 94 Page(s): 398B - 398B
11/15/1999 Authors: Bucur SZ; Heffner LT; Langston AA; Redei J; Waller EK; Winton EF; Holden JT; Smith KJ -
Neurotoxicity associated with the use of tacrolimus following bone marrow transplantation: Noncorrelation with tacrolimus serum level.
BLOOD Volume: 94 Page(s): 334A - 334A
11/15/1999 Authors: Redei I; Langston AA; Cherry JK; Allen A; Waller EK -
Unrelated donor marrow transplantation using a preparative regimen of fractionated TBI, thiotepa, fludarabine, and ATG.
BLOOD Volume: 94 Page(s): 392B - 392B
11/15/1999 Authors: Langston AA; Redei I; Bucur S; Allen A; Cherry JK; Bartlett V; Waller EK -
Salvage therapy with mycophenolate mofetil (MMF) for patients with severe chronic GVHD.
BLOOD Volume: 94 Page(s): 159A - 159A
11/15/1999 Authors: Redei I; Langston AA; Cherry JK; Allen A; Waller EK -
Busulfan/cyclophosphamide/fludarabine (BCF) conditioning prior to volunteer unrelated donor (VUD) bmt for patients with hematologic malignancies: A potential alternative to TBI containing preparative regimens.
BLOOD Volume: 94 Page(s): 567A - 567A
11/15/1999 Authors: Redei I; Langston AA; Bartlett V; Cherry JK; Allen A; Bucur S; Waller EK -
Allogeneic cell transplantation with rhG-CSF mobilized CD34+selected PBPC in conjunction with adoptive immunotherapy for adults with hematologic malignancy.
BLOOD Volume: 94 Page(s): 157A - 157A
11/15/1999 Authors: Redei I; Langston AA; Cherry JK; Allen A; Bucur S; Waller EK -
A novel retinal degeneration locus identified by linkage and comparative mapping of canine early retinal degeneration.
Genomics Volume: 59 Page(s): 134 - 142
07/15/1999 Authors: Acland GM; Ray K; Mellersh CS; Langston AA; Rine J; Ostrander EA; Aguirre GD -
Evaluation of the APOH gene as a positional candidate for prcd in dogs.
Invest Ophthalmol Vis Sci Volume: 40 Page(s): 1229 - 1237
05/01/1999 Authors: Gu W; Ray K; Pearce-Kelling S; Baldwin VJ; Langston AA; Ray J; Ostrander EA; Acland GM; Aguirre GD -
Toward a framework linkage map of the canine genome.
J Hered Volume: 90 Page(s): 7 - 14
01/01/1999 Authors: Langston AA; Mellersh CS; Wiegand NA; Acland GM; Ray K; Aguirre GD; Ostrander EA -
Survival after allogeneic bone marrow transplantation (BMT) is predicted by the number of transplanted donor CD34+ cells and donor dendritic cell progenitors (DCPs).
BLOOD Volume: 92 Page(s): 495A - 495A
11/15/1998 Authors: Waller EK; Lynn MJ; Boyer M; Jones TW; Rosenthal H; Langston A; Lopez R; Bucur S; Hillyer C; Redei I -
Identification of a RAPD marker linked to progressive rod-cone degeneration in dogs.
Mamm Genome Volume: 9 Page(s): 740 - 744
09/01/1998 Authors: Gu W; Acland GM; Langston AA; Ostrander EA; Aguirre GD; Ray K -
Linkage analysis and comparative mapping of canine progressive rod-cone degeneration (prcd) establishes potential locus homology with retinitis pigmentosa (RP17) in humans.
Proc Natl Acad Sci U S A Volume: 95 Page(s): 3048 - 3053
03/17/1998 Authors: Acland GM; Ray K; Mellersh CS; Gu W; Langston AA; Rine J; Ostrander EA; Aguirre GD -
A linkage map of the canine genome.
Genomics Volume: 46 Page(s): 326 - 336
12/15/1997 Authors: Mellersh CS; Langston AA; Acland GM; Fleming MA; Ray K; Wiegand NA; Francisco LV; Gibbs M; Aguirre GD; Ostrander EA -
Construction of a panel of canine-rodent hybrid cell lines for use in partitioning of the canine genome.
Genomics Volume: 46 Page(s): 317 - 325
12/15/1997 Authors: Langston AA; Mellersh CS; Neal CL; Ray K; Acland GM; Gibbs M; Aguirre GD; Fournier RE; Ostrander EA -
Characterization of canine/rodent somatic hybrid cell lines by canine specific amplimers for retina expressed genes
Investigative Ophthalmology and Visual Science Volume: 38
12/01/1997 Authors: Ray K; Langston AA -
Linkage analysis in early retinal degeneration
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 38 Page(s): 1508 - 1508
03/15/1997 Authors: Acland GM; Ostrander EA; Mellersh CS; Langston AA; Rine J; Neff M; Ray K; Aguirre GD -
Hereditary ovarian cancer.
Curr Opin Obstet Gynecol Volume: 9 Page(s): 3 - 7
02/01/1997 Authors: Langston AA; Ostrander EA -
Breast cancer and BRCA1 mutations.
N Engl J Med Volume: 334 Page(s): 1197 - 1198
05/02/1996 Authors: Offit K -
Breast cancer and BRCA1 mutations - Reply
NEW ENGLAND JOURNAL OF MEDICINE Volume: 334 Page(s): 1200 - 1200
05/02/1996 Authors: Langston AA; Malone KE; Ostrander EA -
A class of highly polymorphic tetranucleotide repeats for canine genetic mapping.
Mamm Genome Volume: 7 Page(s): 359 - 362
05/01/1996 Authors: Francisco LV; Langston AA; Mellersh CS; Neal CL; Ostrander EA -
Germ-line BRCA1 mutations in selected men with prostate cancer.
Am J Hum Genet Volume: 58 Page(s): 881 - 885
04/01/1996 Authors: Langston AA; Stanford JL; Wicklund KG; Thompson JD; Blazej RG; Ostrander EA -
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.
Br J Haematol Volume: 92 Page(s): 758 - 765
03/01/1996 Authors: Langston AA; Sanders JE; Deeg HJ; Crawford SW; Anasetti C; Sullivan KM; Flowers ME; Storb R -
BRCA1 mutations in a population-based sample of young women with breast cancer.
N Engl J Med Volume: 334 Page(s): 137 - 142
01/18/1996 Authors: Langston AA; Malone KE; Thompson JD; Daling JR; Ostrander EA -
Tissue-specific extinguisher loci in the human genome: a screening study based on random marking and transfer of human chromosomes.
Somat Cell Mol Genet Volume: 20 Page(s): 215 - 231
05/01/1994 Authors: Shapero MH; Langston AA; Fournier RE -
Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome.
Rev Infect Dis Volume: 12 Page(s): 583 - 590
01/01/1990 Authors: Kim JH; Langston AA; Gallis HA -
Herpes simplex virus encephalitis: the need for early diagnosis.
N C Med J Volume: 47 Page(s): 17 - 19
01/01/1986 Authors: Shaw GL; Langston AA -
Antibodies to bovine leukemia virus in a leukosis dairy herd and suggestions for control of the infection.
Can J Comp Med Volume: 43 Page(s): 173 - 179
04/01/1979 Authors: Ferdinand GA; Langston A; Ruppanner R; Drlica S; Theilen GH; Behymer DE -
Comparison of production variables of bovine leukemia virus antibody-negative and antibody-positive cows in two California dairy herds.
Am J Vet Res Volume: 39 Page(s): 1093 - 1098
07/01/1978 Authors: Langston A; Ferdinand GA; Ruppanner R; Theilen GH; Drlica S; Behymer D -
Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
Online Journal of Public Health Informatics Volume: 6
Authors: Shah N; Nooka AK; Lonial S; Khoury HJ; Waller E; Langston A